Results 31 to 40 of about 2,507,641 (307)

Adjuvant and neoadjuvant therapies in melanoma [PDF]

open access: yesESMO Open, 2020
Click here to listen to the Podcast.
Kok Haw Jonathan Lim, Teresa Amaral
openaire   +4 more sources

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma

open access: yesJournal of the National Cancer Center, 2022
: Objective: This is a prospective, single-arm, phase Ib study to evaluate the safety and efficacy of camrelizumab combined with chemotherapy and apatinib as neoadjuvant therapy for locally advanced thoracic esophageal squamous cell carcinoma (ESCC ...
Zhen Wang   +14 more
doaj   +1 more source

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

open access: yesFrontiers in Oncology, 2021
BackgroundImmune checkpoint inhibitors (ICIs) have shown promising anti-tumor activity in multiple malignances including breast cancer. However, the responses can vary.
Yunhai Li   +10 more
doaj   +1 more source

Supersensitive PSA-Monitored neoadjuvant hormone treatment of clinically localized prostate cancer: Effects on positive margins, tumor detection and epithelial cells in bone marrow [PDF]

open access: yes, 1998
Objective: The present study was done to investigate the effects of supersensitive PSA-controlled inductive treatment on positive margins, detection of tumor and epithelial cells in bone marrow of 101 patients with untreated and clinically localized ...
Köllermann, J.   +7 more
core   +1 more source

Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward

open access: yes, 2022
The cornerstone of therapy for primary retroperitoneal sarcomas (RPS) is complete surgical resection, best achieved by resecting the tumor en bloc with adherent structures even if not overtly infiltrated.
Alexandra C. Istl, Alessandro Gronchi
core   +1 more source

Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?

open access: yesAnnals of Gastroenterological Surgery, 2020
Although upfront surgery has been the gold standard for pancreatic adenocarcinoma that is planned for resection, it should be compared with the alternative strategy of neoadjuvant therapy.
Fuyuhiko Motoi, Michiaki Unno
doaj   +1 more source

Post-Neoadjuvant Treatment Strategies in Breast Cancer

open access: yes, 2022
Neoadjuvant chemotherapy enables close monitoring of tumor response in patients with breast cancer. Being able to assess tumor response during treatment provides an opportunity to evaluate new therapeutic strategies.
Bálint Tamaskovics   +12 more
core   +1 more source

Neoadjuvant therapy for pancreatic cancer [PDF]

open access: yesUpdates in Surgery, 2021
Multimodal treatment including surgery and chemotherapy is considered the gold standard treatment of pancreatic cancer by most guidelines. Neoadjuvant therapy (NAT) has been seen as a possible treatment option for resectable, borderline resectable and locally advanced PaC.
Jean Gugenheim   +2 more
openaire   +2 more sources

Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer

open access: yes, 2023
Despite aggressive adjuvant management, a high percentage of patients who undergo appropriate surgical resection for pancreatic cancer will see their cancer recur and thus will not be cured. An important paradigm shift to achieve better outcomes has been
Brandon G. Smaglo
core   +1 more source

The Role of VEGFA, COX2, HUR and CUGBP2 in Predicting the Response to Neoadjuvant Therapy in Rectal Cancer Patients

open access: yesMedicina, 2020
Background and objectives: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore, the
Henrikas Pauzas   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy